EYE » Topics » EXPLANATORY NOTE

This excerpt taken from the EYE 8-K filed Aug 26, 2008.

EXPLANATORY NOTE

On April 2, 2007, Advanced Medical Optics, Inc. (the “Company”), a Delaware corporation, completed the acquisition of all the outstanding voting securities of IntraLase Corp.

The Company is filing this Current Report on Form 8-K in connection with the filing of the Company’s registration statement on Form S-3 on August 26, 2008 to include unaudited pro forma condensed combined financial information reflecting the acquisition of IntraLase Corp., as updated through December 31, 2007.

 

Item 9.01 Financial Statements and Exhibits

 

  (b) Pro Forma Financial Information

The unaudited pro forma condensed combined statement of operations reflecting the acquisition of IntraLase Corp. through December 31, 2007 are attached hereto as Exhibit 99.1.

 

  (d) Exhibits

 

99.1    Unaudited pro forma condensed combined statement of operations described in 9.01(b).


This excerpt taken from the EYE 10-Q filed Nov 8, 2007.

EXPLANATORY NOTE

This Amendment No. 1 to our Quarterly Report on Form 10-Q for the quarterly period ended September 28, 2007 reflects a correction of clerical errors in the Notes to Unaudited Consolidated Financial Statements in Item 1, Financial Statements. The condensed consolidating statement of cash flows for the nine months ended September 29, 2006, as set forth in Note 6 on page 18 of the Form 10-Q as filed on November 7, 2007 has been revised as follows: (a) the amounts presented in the line item “Net cash provided by operating activities” of Parent, Guarantor Subsidiaries and Non-Guarantor Subsidiaries were incorrectly stated as $151,737, $211,203 and $(174,696), respectively, when the correct amounts should be $156,509, $3,619 and $28,116, respectively, and (b) the amounts presented in the line item “Cash and equivalents at beginning of period” of Parent, Guarantor Subsidiaries and Non-Guarantor Subsidiaries were incorrectly stated as $7,878, $(206,599) and $239,547, respectively, when the correct amounts should be $3,106, $985 and $36,735, respectively. These errors had no impact on the consolidated financial statements in Item 1 and had no impact on Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations. Other than these changes, the remainder of the document is unchanged from the original filing.

 

2


Table of Contents

EXCERPTS ON THIS PAGE:

8-K
Aug 26, 2008
10-Q
Nov 8, 2007
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki